130C3/2B/8細胞

生長狀態： 懸浮生長

是否是腫瘤細胞： 0

物種來源： 小鼠

細胞形態： **樣

**類型： IgG1

ATCC Number： HB-8088?

130C3/2B/8細胞運輸方式： 凍存運輸

數量： 大量

Designations: 130C3/2B/8

Depositors: Johns Hopkins University

Isotype: IgG1

Biosafety Level: 1

Shipped: frozen

Medium & Serum: See Propagation

130C3/2B/8細胞Growth Properties: suspension

Organism: Mus musculus (B cell); Mus musculus (myeloma) deposited as mouse (B cell); mouse (myeloma)

Morphology: lymphoblast

Source: Cell Type: hybridoma: B lymphocyte;

Cellular Products: immunoglobulin; monoclonal antibody; against surface (cercariae) glycoprotein on Schistosoma mansoni

Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.

Comments: 130C3/2B/8細胞Animals were immunized with cercariae glycoprotein from Schistosoma mansoni.

Spleen cells were fused with P3X63Ag8 myeloma cells.

Propagation: ATCC complete growth medium: Dulbecco's modified Eagle's medium with 4.5 g/L glucose, 0.2 units/ml insulin, 3 mM L-glutamine, 1 mM sodium pyruvate, 0.15 mg/ml oxaloacetic acid and 0.01 M HEPES, 80%; NCTC 135 medium, 10%; fetal bovine serum, 10%

Subculturing: Medium Renewal: Every 2 to 3 days

Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml.

Preservation: culture medium, 40%; fetal bovine serum, 50%; DMSO, 10%

Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 46-X

References: 3511: Strand M. Diagnosis and treatment of fluke infections with monoclonal antibodies. 130C3/2B/8細胞US Patent 4,416,866 dated Nov 22 1983